Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis

BackgroundThe clinical benefits of high-dose intravenous immunoglobulin (IVIg) in treating COVID-19 remained controversial.MethodsWe systematically searched databases up to February 17, 2022, for studies examining the efficacy of IVIg compared to routine care. Meta-analyses were conducted using the...

Full description

Bibliographic Details
Main Authors: Xiaosheng Liu, Yuelun Zhang, Lianfeng Lu, Xiaodi Li, Yuanni Wu, Yang Yang, Taisheng Li, Wei Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
COVID-19
IVIg
systemic review
meta-analysis
meta-regression
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1116738/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1116738/full

Similar Items